Previous
  • In this issue we discuss the importance of vaccination for children under five to prevent debilitating and potentially fatal diseases. We also visit South Africa, where one young woman's story illustrates the critical need for access to medicines, and two MSF field workers in war-torn Syria recount their experiences.

  • A forgotten war in northern Uganda. Violence in Ivory Coast. MSF's efforts to fight measles in Darfur. Mental health care in times of conflict. Responding to emergencies in the Congo. On the frontlines of AIDS treatment. Closing programs in Iraq. All in this issue of Alert.

  • The project coordinator of an MSF team in Abidjan, Ivory Coast, kept a diary describing the tense and often overwhelming period of fighting when staff worked continuously to treat the wounded and sick. And, an MSF study in Niger shows how effective ready-to-use foods can be in a malnutrition emergency.

  • In this issue, we take you inside the neglected crisis in Central African Republic, in addition to stories on Chad, access to medicines, and surgery in war-torn Syria.

  • In this issue, we focus on MSF's work in the Democratic Republic of Congo, where the ongoing conflict has physically and emotionally traumatized its people. We also consider other pertinent health and medical issues, such as Trans-Pacific Partnership; drug-resistent tuberculosis; and Rohingya refugees in Bangladesh.

  • In this issue, MSF staff answer fundamental questions about our operations—from how we recruit staff, respond to emergencies, and deliver supplies, to how we close projects and share our medical findings with the global health community.

  • Welcome to our new Alert. This is the first issue of MSF-USA’s re-designed quarterly newsletter, and we hope you like it. This issue of Alert highlights devastating crises in South Sudan and Syria, conflict-related emergencies that are causing mass casualties and extensive displacement. In both places (and in neighboring countries), our medical teams are doing as much as they can to ease suffering and save lives.

  • Two years after a 7.0-magnitude earthquake left much of the country's already fragile infrastructure in tatters, the people of Haiti remain in desperate need of assistance. In this issue, a look at Drouillard Hospital, an MSF-run facility in the Cite Soleil slum of Port-au-Prince where MSF provides the city's only free treatment for severe burns. Also in this issue: a project update on MSF's efforts to combat chronic malnutrition in Africa's Sahel region, an interview with the head of MSF's Emergency Team, and a field journal from HIV/AIDS Policy Adviser Sharonann Lynch, who recently visited an innovative HIV care program in rural Mozambique.

  • While MSF has been unable to work directly in Syria, it has collected testimonies from wounded patients treated outside the country and from doctors inside Syria. These testimonies point to a coordinated crackdown on the provision of urgent medical care for people wounded in Syria's ongoing violence. Also in this issue: MSF field journals from Gogrial and Doro in South Sudan, an interview with Emmanuel Baron, executive director of Epicentre, and photos from MSF's trauma center in Kunduz, Afghanistan.

  • This special "Year in Pictures" issue brings you images from MSF's activities all over the world in 2011. These photos chronicle the response to the humanitarian crisis in the Horn of Africa; ongoing programs in conflict-affected areas of Afghanistan, Ivory Coast, Libya, and others; the birth of South Sudan, the world's newest nation; MSF's continuing work in the Democratic Republic of Congo; and more. Also read a new Field Journal from an MSF nurse who spent 14 months in Haiti providing care in the aftermath of the earthquake.

Next

Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

April 21, 2016

In advance of the next round of the Regional Comprehensive Economic Partnership (RCEP) negotiations starting in Perth, Australia, this Sunday, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is warning that current proposals in this trade agreement could severely restrict access to affordable medicines for millions of people around the world. Text from a leaked chapter on intellectual property shows that Japan and South Korea have made proposals that go beyond what international trade rules require, undermining access to affordable generic medicines and making it harder for patients and treatment providers like MSF to access affordable, lifesaving medicines.

April 12, 2016

More than fifty groups have come together to demand that the US Congress reject the Trans-Pacific Partnership Trade Deal (TPP) due to provisions it contains that would undermine public health. In a letter sent to Congress today, the groups outlined the damaging effects the trade deal would have on public health, and said lawmakers should not vote for the TPP unless damaging provisions are removed.

April 07, 2016

Operational Update

BRUSSELS/NEW YORK—Despite a ceasefire in fighting and the arrival of humanitarian convoys, the situation remains critical in many besieged areas of Syria, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Thursday.   

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

March 09, 2016

New York— A Senate committee voted today to add Zika to the list of diseases eligible for the US Federal Drug Administration (FDA) Priority Review Voucher (PRV) program for neglected diseases, but did not fix major loopholes that make the PRV program for neglected diseases ripe for abuse by pharmaceutical companies.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

February 25, 2016

After a recent large fire destroyed the makeshift shelters and belongings of at least 449 families in the Batangafo displaced persons camp, one of the largest in Central African Republic (CAR), Doctors Without Borders/Médecins Sans Frontières (MSF) teams rapidly organized to distribute emergency kits including cooking and hygiene items for those affected.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

Pages